Sep 15, 2016 12:00 pm UTC| Business
BOTHELL, Wash., Sept. 15, 2016 -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics, today announced the presentation of data from Phase...
Sep 15, 2016 11:57 am UTC| Business
MIDDLETOWN, R.I., Sept. 15, 2016 -- Towerstream Corporation (NASDAQ:TWER) (the “Company”), a leading Fixed-Wireless Fiber Alternative company, announces Ernie Ortega will be expanding his role with the company. Ernie...
Sep 15, 2016 11:45 am UTC| Business
SOUTH SAN FRANCISCO, Calif., Sept. 15, 2016 -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical stage biotechnology company focused on the development of novel cancer therapeutics, today announced that the first...
Sep 15, 2016 11:30 am UTC| Business
BRUSSELS, Belgium, Sept. 15, 2016 -- WABCO Holdings Inc. (NYSE:WBC) (www.wabco-auto.com), a leading global supplier of technologies that improve the safety, efficiency and connectivity of commercial vehicles, today...
Sep 15, 2016 11:30 am UTC| Business
SAN DIEGO, Sept. 15, 2016 -- Otonomy, Inc. (Nasdaq:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today...
Sep 15, 2016 11:30 am UTC| Business
$21 Million in Private Placements, Funded in Two Tranches, Including $5 Million fromSanford Health to Support Type 1 Diabetes Candidate Development $4 Million in a Registered Direct Offering to an Existing Institutional...
Voyager Therapeutics Licenses Novel Gene Therapy Capsids from the California Institute of Technology
Sep 15, 2016 11:05 am UTC| Business
CAMBRIDGE, Mass., Sept. 15, 2016 -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe diseases of the central nervous system (CNS), today...